Fasting for Kidney Disease - Surprising Benefits | Jason Fung
The Fasting MethodPublished on December 7, 2024
Summary authored by editor@wellifi.com
TLDR Summary
Recent studies suggest that fasting can significantly benefit kidney health by reversing diabetic kidney disease and reducing inflammation. Emerging research indicates that fasting may also help manage other types of kidney diseases, including polycystic kidney disease.
Key Points
- Fasting mimicking diet can reverse established diabetic kidney disease.
- Fasting reduces protein spilling in urine, a key marker of kidney disease severity.
- Nutrient sensors like insulin and mTOR play crucial roles in kidney health.
- Animal studies show fasting improves kidney function and reduces damage.
- Human trials indicate fasting can decrease inflammation and stimulate kidney cell regeneration.
- Fasting may also positively impact polycystic kidney disease.
Fasting and Its Potential Benefits for Kidney Disease
Fasting has garnered attention in recent years for its potential health benefits, particularly regarding kidney disease. Exciting research has emerged, suggesting that fasting can positively impact various forms of kidney disease. In this article, we will explore some of the key findings surrounding fasting and kidney health.
The Science Behind Fasting and Kidney Disease
In 2022, a pivotal study revealed that a fasting mimicking diet could reverse established diabetic kidney disease. This six-month intervention demonstrated a significant reduction in protein spilling in urine, a critical marker for kidney disease severity. Moreover, further research by El Nutra has suggested that other forms of kidney disease, including glomerular diseases and chronic kidney diseases, may also benefit from fasting.
Understanding Nutrient Sensors
Growth in the human body, particularly in adults, can lead to excess scarring and fibrosis, negative consequences for kidney health. The body utilizes nutrient sensors to determine whether nutrients are available. Insulin is a primary nutrient sensor, while mTOR (mechanistic target of rapamycin) has gained recognition in recent years as a key player in nutrient sensing, primarily responding to protein intake.
Fasting effectively reduces the activity of both insulin and mTOR, lowering growth signals that could exacerbate kidney disease. Unlike dietary changes alone, fasting effectively decreases both signals at the same time, providing a unique therapeutic approach.
Animal Studies and Human Trials
Initial studies conducted on rats showed promising results. Rats subjected to a low-salt fasting mimicking diet exhibited a marked improvement in urine protein to creatinine ratios, indicating improved kidney function. Histological analysis showed reduced tubular damage and gene expression patterns closer to those of healthy rats.
Building on these findings, researchers conducted a limited trial with 13 humans suffering from various glomerular diseases. The fasting mimicking diet led to around a 30% decrease in urinary protein levels and significant reductions in inflammatory markers like CRP. This suggests a potential healing process influenced by reduced inflammation and enhanced kidney progenitor cell stimulation.
Polycystic Kidney Disease and Fasting
Fasting may also hold promise for polycystic kidney disease, a genetic disorder characterized by the formation of numerous kidney cysts. Animal studies have indicated that food restriction could normalize kidney size and preserve function despite the genetic nature of the disease. These findings suggest that fasting could influence growth factors that exacerbate cyst development.
Conclusion
Fasting appears to be a promising avenue for managing various types of kidney disease. From diabetic kidney disease to polycystic kidney disease, emerging research indicates that fasting can lead to significant improvements in kidney function and inflammation. As we await further human studies, the potential role of fasting in kidney health offers a hopeful perspective for patients and healthcare providers alike.